HOME >> MEDICINE >> NEWS
Alcohol-deterrent drugs help patients achieve high rates of long-term abstinence

  • A nine-year study looks at the impact of alcohol deterrents (ADs) disulfiram and calcium carbimide.
  • Researchers found an abstinence rate of more than 50 percent among the patients studied.
  • ADs appear to play a major psychological role in relapse prevention.

Studies investigating the long-term outcomes of alcoholism treatment are rare and inconsistent. A nine-year study in the January issue of Alcoholism: Clinical & Experimental Research investigates the occurrence of abstinence, lapse, and relapse among chronic alcoholics while exploring the role that "alcohol deterrents" (ADs) specifically, disulfiram and calcium carbimide may play. Results indicate that ADs can help achieve an abstinence rate of more than 50 percent.

"Although up to 30 percent of patients may claim to be abstinent two to three years after treatment," said Hannelore Ehrenreich, head of the division of clinical neuroscience at the Max-Planck-Institute of Experimental Medicine in Germany and corresponding author for the study, "objective laboratory data indicate that only six to 20 percent of patients are abstinent two years after therapy. These results reflect therapists' clinical experience that alcoholism is a chronic and relapsing disease similar to other chronic conditions such as hypertension or diabetes, and should be accepted as a disorder that requires long-term or life-long treatment. This study is the first report on supervised, long-term administration of ADs, with a focus on the psychological rather than the pharmacological action of ADs."

Alcohol deterrents seem to be more widely accepted and used in Europe than they are in North America, said Colin Brewer, research director of the Stapleford Centre in London. "I have co-authored a study showing that the three 'Anglo-Saxon' countries examined the U.K, U.S. and New Zealand had the lowest use," he said. "Furthermore, a recent U.S. study show
'"/>


3-Jan-2006


Page: 1 2 3 4

Related medicine news :

1. UIC researchers to develop new drugs to fight bioterrorism
2. Statin drugs may delay progressive artery damage in children
3. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
4. Experts call for urgent research into anti-epileptic drugs given to children
5. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
6. Antipsychotic drugs increase risk of death in older people with dementia
7. Antipsychotic drugs increase risk of death in older people with dementia
8. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
9. Panel offers guidelines on skin reactions to new class of cancer drugs
10. Blood-thinning drugs need closer monitoring
11. Comparison of patients access to new and better cancer drugs reveals inequalities between countries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... Bastyr University ... Academy of Integrative Health and Medicine’s (AIHM) Visionary Award for his passionate efforts ... Dr. Pizzorno was selected as AIHM’s recipient of the Visionary Award due to ...
(Date:10/16/2018)... Del. (PRWEB) , ... October 16, 2018 , ... ... of First Healthcare Compliance, an attorney experienced in employment law, writes frequently on ... other publications. Recently, she authored a chapter in the Health Care Compliance Professional's ...
(Date:10/16/2018)... ... October 16, 2018 , ... BlueCloud ... by patient-survivors, and The Avoca Group, Inc., a life sciences consulting firm ... today announced its mutual collaboration that will make Avoca’s industry research results, ...
(Date:10/13/2018)... NEW YORK (PRWEB) , ... October 13, 2018 , ... ... will show the world that it IS possible to end hunger by 2030 by ... to bring volunteers from several of their 28 U.S. based locations and five international ...
(Date:10/11/2018)... Fla. (PRWEB) , ... October 11, 2018 , ... ... integrity to a diverse range of healthcare organizations nationwide, announced today the launch ... essential information on the Company’s portfolio of services while offering a more comprehensive ...
Breaking Medicine News(10 mins):
(Date:10/13/2018)... ... October 12, 2018 , ... David Young was ... was used in the Lockheed F22 Aircraft. Today, he announces the invention of ... which can lead to sudden cardiac death (SCD). , The Two-Dimensional Arrhythmia Monitor ...
(Date:10/13/2018)... ... ... In the world of contract manufacturing, Ion Labs is currently in a ... a game-changing year for Ion Labs . Expansions in the form of personnel, ... Labs attributes its growth to its responsiveness to customer inquiries, staying in close communication ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... communications, billing, and payments solutions, announced today that it has completed the ... a premier healthcare provider of patient revenue cycle engagement, billing, and payments ...
Breaking Medicine Technology:
Cached News: